University Heart Center Freiburg - Bad Krozingen
13
1
1
6
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 50/100
7.7%
1 terminated/withdrawn out of 13 trials
85.7%
-0.8% vs industry average
23%
3 trials in Phase 3/4
0%
0 of 6 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (13)
Radial Versus Femoral Secondary Access in Patients Undergoing TAVI
Role: lead
Improved Self-management for Patients on Ventricular Assist Device (VAD) Support - Phase 3
Role: collaborator
Culotte Versus DK-CRUSH Technique in Non-left Main Coronary Bifurcation Lesions
Role: lead
European/Euro-ELSO Survey on Adult and Neonatal/ Pediatric COVID-19 Patients in ECMO
Role: collaborator
Improved Self-management for Patients on Ventricular Assist Device (VAD)
Role: collaborator
German Epicardial Collateral CTO Registry
Role: collaborator
Recovery of Left Ventricular Function in Chronic Total Occluded Coronary Arteries
Role: lead
Culotte Technique Versus TAP Stunting for the Treatment of de Novo Coronary Bifurcation Lesion With Drug-eluting Stents
Role: lead
Paclitaxel-Coated Versus Uncoated Balloon for Treatment of Below-the-Knee In-Stent-Restenosis
Role: collaborator
Troponin T as Risk Stratification Tool in Peripheral Arterial Occlusive Disease
Role: lead
Treatment of Bifurcated Coronary Lesions With Cypher™-Stent
Role: lead
Effect of Clopidogrel Loading and Risk of PCI
Role: lead
Efficacy of Adjusted Clopidogrel Dose in Patients With Insufficient Platelet Inhibition
Role: lead
All 13 trials loaded